Androgel: Clinical Trials

8 trials of Androgel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 withdrawn. 8 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 5, Terminated 2, Withdrawn 1
Phase 22Completed 2

Follow Androgel: new trials by email Literature Review of Androgel trials Research Report on Androgel

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men
Nestorone® /testosterone gel, Testosterone only gel - Healthy
Phase 1CompletedKimberly Myer442015-04-012025-02-13
T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin
Acyline, Testosterone 1.62% gel, Letrozole - Insulin Resistance, Type 2 Diabetes Mellitus
Phase 1 / Phase 2CompletedUniversity of Washington532013-06-012018-05-08
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
Acyline, Testosterone gel, ketoconazole 400 - Healthy Males
Phase 1 / Phase 2CompletedUniversity of Washington462011-01-012014-03-31
Influence of Male Hormones on Regional Fat Metabolism
Leuprolide, Testosterone - Obesity
Phase 1CompletedMayo Clinic392010-06-012014-05-14
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)
Anastrozole Pill, Testosterone, Placebo Oral Tablet - Hypogonadotropic Hypogonadism, Kallmann Syndrome
Phase 1TerminatedMassachusetts General Hospital72010-05-012017-04-18
Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome
Zoladex, Testosterone gel, Anastrozole Pill - Metabolic Syndrome
Phase 1TerminatedMassachusetts General Hospital662006-09-012017-04-18
A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED).
testosterone gel, Comparator: placebo - Skin Androgenization
Phase 1CompletedMerck Sharp & Dohme LLC302004-10-012014-09-04
Influence of Administration Route of Testosterone on Male Fertility
MPP10, testosterone, Testosterone - Hypogonadism
Phase 1WithdrawnAcerus Pharmaceuticals Corporation2018-03-13

Conditions studied

Obesity (3)  ·  Hypogonadism (2)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Idiopathic Hypogonadotropic Hypogonadism (1)  ·  Insulin Resistance (1)  ·  Kallmann Syndrome (1)  ·  Metabolic Diseases (1)  ·  Metabolic Syndrome (1)  ·  Overweight (1)

Sponsors

Massachusetts General Hospital (2)  ·  University of Washington (2)  ·  Acerus Pharmaceuticals Corporation (1)  ·  Kimberly Myer (1)  ·  Mayo Clinic (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (6)  ·  Netherlands (1)

Top investigators

Christina Wang, MD (1)  ·  Frances J Hayes, MD (1)  ·  Katya Rubinow, MD (1)  ·  Mara Y Roth, MD (1)  ·  Margarita Budumian, MD (1)  ·  Michael D Jensen, M.D. (1)  ·  Nelly Pitteloud, MD (1)  ·  Stephanie T Page, MD, PhD (1)  ·  William Bremner, MD (1)  ·  William J Bremner, MD, PhD (1)

Results publications

PMID 23348398, PMID 27482750, PMID 29793828

NIH funding

R01DK045343 (1), U54HD012629 (1)